Related references
Note: Only part of the references are listed.The Putative S1PR1 Modulator ACT-209905 Impairs Growth and Migration of Glioblastoma Cells In Vitro
Sandra Bien-Moeller et al.
CANCERS (2023)
Hallmarks of Cancer: New Dimensions
Douglas Hanahan
CANCER DISCOVERY (2022)
Rat and Mouse Brain Tumor Models for Experimental Neuro-Oncology Research
Upasana Sahu et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2022)
Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T cells response
Tristan Rupp et al.
TRANSLATIONAL ONCOLOGY (2022)
Targeting Oncogenic Rewiring of Lipid Metabolism for Glioblastoma Treatment
Haksoo Lee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
A Face-To-Face Comparison of Tumor Chicken Chorioallantoic Membrane (TCAM) In Ovo with Murine Models for Early Evaluation of Cancer Therapy and Early Drug Toxicity
Tristan Rupp et al.
CANCERS (2022)
Therapeutic Potential of Fingolimod and Dimethyl Fumarate in Non-Small Cell Lung Cancer Preclinical Models
Tristan Rupp et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Cholesterol metabolism and its implication in glioblastoma therapy
Xuyang Guo et al.
JOURNAL OF CANCER (2022)
Therapeutic potential of Fingolimod in triple negative breast cancer preclinical models
Tristan Rupp et al.
TRANSLATIONAL ONCOLOGY (2021)
Acting centrally or peripherally: A renewed interest in the central nervous system penetration of disease-modifying drugs in multiple sclerosis
Jorge Correale et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)
Drug resistance evaluation in novel 3D in vitro model
Marta Nowacka et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
Reprogramming the immunosuppressive microenvironment of IDH1 wild-type glioblastoma by blocking Wnt signaling between microglia and cancer cells
Dandan Fan et al.
ONCOIMMUNOLOGY (2021)
Targeting the S1P receptor signaling pathways as a promising approach for treatment of autoimmune and inflammatory diseases
Bisera Stepanovska et al.
PHARMACOLOGICAL RESEARCH (2020)
Fingolimod promotes angiogenesis and attenuates ischemic brain damage via modulating microglial polarization
Ke Shang et al.
BRAIN RESEARCH (2020)
Sphingosine-1-Phosphate in the Tumor Microenvironment: A Signaling Hub Regulating Cancer Hallmarks
Laura Riboni et al.
CELLS (2020)
Fingolimod Augments Monomethylfumarate Killing of GBM Cells
Paul Dent et al.
FRONTIERS IN ONCOLOGY (2020)
Non-Mitogenic Fibroblast Growth Factor 1 Enhanced Angiogenesis Following Ischemic Stroke by Regulating the Sphingosine-1-Phosphate 1 Pathway
Yuchi Zou et al.
FRONTIERS IN PHARMACOLOGY (2020)
FTY720 Exerts Anti-Glioma Effects by Regulating the Glioma Microenvironment Through Increased CXCR4 Internalization by Glioma-Associated Microglia
Xu-Dong Guo et al.
FRONTIERS IN IMMUNOLOGY (2020)
Comparative Molecular Analysis of Cancer Behavior Cultured In Vitro, In Vivo, and Ex Vivo
Nicholas R. Hum et al.
CANCERS (2020)
S1PR2 inhibitors potently reverse 5-FU resistance by downregulating DPD expression in colorectal cancer
Yu-Hang Zhang et al.
PHARMACOLOGICAL RESEARCH (2020)
S1PR4 ablation reduces tumor growth and improves chemotherapy via CD8(+) T cell expansion
Catherine Olesch et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Developing a clinically relevant radiosensitizer for temozolomide-resistant gliomas
Radu O. Minea et al.
PLOS ONE (2020)
Induction of Lysosomal Membrane Permeabilization Is a Major Event of FTY720-Mediated Non-Apoptotic Cell Death in Human Glioma Cells
Kyoung-jin Min et al.
CANCERS (2020)
Is It Time to Start Transitioning From 2D to 3D Cell Culture?
Caleb Jensen et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
ATRX loss induces telomere dysfunction and necessitates induction of alternative lengthening of telomeres during human cell immortalization
Fei Li et al.
EMBO JOURNAL (2019)
The effect of 2D and 3D cell cultures on treatment response, EMT profile and stem cell features in head and neck cancer
Styliani Melissaridou et al.
CANCER CELL INTERNATIONAL (2019)
Association of patterns of care, prognostic factors, and use of radiotherapy-temozolomide therapy with survival in patients with newly diagnosed glioblastoma: a French national population-based study
Pascale Fabbro-Peray et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Treatment of multiple sclerosis - success from bench to bedside
Mar Tintore et al.
NATURE REVIEWS NEUROLOGY (2019)
Prognostic factors for survival in adult patients with recurrent glioblastoma: a decision-tree-based model
Etienne Audureau et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Molecular targeted therapy: Treating cancer with specificity
Yeuan Ting Lee et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Multidimensional communication in the microenvirons of glioblastoma
Marike L. Broekman et al.
NATURE REVIEWS NEUROLOGY (2018)
The role of sphingosine-1-phosphate in inflammation and cancer progression
Masayuki Nagahashi et al.
CANCER SCIENCE (2018)
Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models
Vassilis Genoud et al.
ONCOIMMUNOLOGY (2018)
A Novel Venom-Derived Peptide for Brachytherapy of Glioblastoma: Preclinical Studies in Mice
Steve Swenson et al.
MOLECULES (2018)
Sphingosine 1-Phosphate (S1P) Signaling in Glioblastoma MultiformeA Systematic Review
Shailaja Mahajan-Thakur et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Immune microenvironment of gliomas
Anna Gieryng et al.
LABORATORY INVESTIGATION (2017)
FTY720/fingolimod, an oral S1PR modulator, mitigates radiation induced cognitive deficits
Alexander M. Stessin et al.
NEUROSCIENCE LETTERS (2017)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
FTY720 inhibits the Nrf2/ARE pathway in human glioblastoma cell lines and sensitizes glioblastoma cells to temozolomide
Li Zhang et al.
PHARMACOLOGICAL REPORTS (2017)
Modeling Physiological Events in 2D vs. 3D Cell Culture
Kayla Duval et al.
PHYSIOLOGY (2017)
Radiotherapy plus temozolomide in elderly patients with glioblastoma: a real-life report
J. Biau et al.
RADIATION ONCOLOGY (2017)
Incurred sample reanalysis of fingolimod and fingolimod phosphate in blood: stability evaluation and application to a rat pharmacokinetic study
Ramakrishna Nirogi et al.
BIOANALYSIS (2017)
Organotypic three-dimensional cancer cell cultures mirror drug responses in vivo: lessons learned from the inhibition of EGFR signaling
Nico Jacobi et al.
ONCOTARGET (2017)
Dynamic stroma reorganization drives blood vessel dysmorphia during glioma growth
Thomas Mathivet et al.
EMBO MOLECULAR MEDICINE (2017)
Human U87 glioblastoma cells with stemness features display enhanced sensitivity to natural killer cell cytotoxicity through altered expression of NKG2D ligand
Se-Jeong Oh et al.
CANCER CELL INTERNATIONAL (2017)
The Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple Sclerosis
Samuel F. Hunter et al.
CNS DRUGS (2016)
FTY720 (Fingolimod) Inhibits HIF1 and HIF2 Signaling, Promotes Vascular Remodeling, and Chemosensitizes in Renal Cell Carcinoma Animal Model
Cecile Gstalder et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Validation of the high-performance of pyrosequencing for clinical MGMT testing on a cohort of glioblastoma patients from a prospective dedicated multicentric trial
Veronique Quillien et al.
ONCOTARGET (2016)
Expression of S1P metabolizing enzymes and receptors correlate with survival time and regulate cell migration in glioblastoma multiforme
Sandra Bien-Moeller et al.
ONCOTARGET (2016)
The emerging role of FTY720 (Fingolimod) in cancer treatment
Christopher White et al.
ONCOTARGET (2016)
3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained
Michele Zanoni et al.
SCIENTIFIC REPORTS (2016)
Temozolomide resistance in glioblastoma multiforme
Sang Y. Lee
GENES & DISEASES (2016)
Interference with distinct steps of sphingolipid synthesis and signaling attenuates proliferation of U87MG glioma cells
Eva Bernhart et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Preclinical Mouse Cancer Models: A Maze of Opportunities and Challenges
Chi-Ping Day et al.
CELL (2015)
The antineoplastic properties of FTY720: evidence for the repurposing of fingolimod
Sathya Narayanan Patmanathan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone
Jean-Michel Lemee et al.
NEURO-ONCOLOGY (2015)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2015)
FTY720 induces autophagy-related apoptosis and necroptosis in human glioblastoma cells
Li Zhang et al.
TOXICOLOGY LETTERS (2015)
FTY720 enhances TRAIL-mediated apoptosis by up-regulating DR5 and down-regulating Mcl-1 in cancer cells
Seon Min Woo et al.
ONCOTARGET (2015)
IDH mutation and MGMT promoter methylation in glioblastoma: results of a prospective registry
Pei Yang et al.
ONCOTARGET (2015)
Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma
Serena Pellegatta et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2015)
Antitumor Activity of a Novel Sphingosine-1-Phosphate 2 Antagonist, AB1, in Neuroblastoma
Mei-Hong Li et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
The tumor suppressor prostate apoptosis response-4 (Par-4) is regulated by mutant IDH1 and kills glioma stem cells
Yinxing Liu et al.
ACTA NEUROPATHOLOGICA (2014)
Toxicity Profile of Temozolomide in the Treatment of 300 Malignant Glioma Patients in Korea
So Hyun Bae et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2014)
The Role of Gene Body Cytosine Modifications in MGMT Expression and Sensitivity to Temozolomide
Erika L. Moen et al.
MOLECULAR CANCER THERAPEUTICS (2014)
FTY720 reduces migration and invasion of human glioblastoma cell lines via inhibiting the PI3K/AKT/mTOR/p70S6K signaling pathway
Li Zhang et al.
TUMOR BIOLOGY (2014)
AngioMatrix, a signature of the tumor angiogenic switch-specific matrisome, correlates with poor prognosis for glioma and colorectal cancer patients
Benoit Langlois et al.
ONCOTARGET (2014)
Translational Pharmacokinetic Modeling of Fingolimod (FTY720) as a Paradigm Compound Subject to Sphingosine Kinase-Mediated Phosphorylation
Nelleke Snelder et al.
DRUG METABOLISM AND DISPOSITION (2014)
Differentiation Patterns of Embryonic Stem Cells in Two- versus Three-Dimensional Culture
Emma T. Pineda et al.
CELLS TISSUES ORGANS (2013)
A Metabolic Shift Favoring Sphingosine 1-Phosphate at the Expense of Ceramide Controls Glioblastoma Angiogenesis
Hazem J. Abuhusain et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
The Cancer Genome Atlas Pan-Cancer analysis project
John N. Weinstein et al.
NATURE GENETICS (2013)
The Genotype-Tissue Expression (GTEx) project
John Lonsdale et al.
NATURE GENETICS (2013)
Fingolimod potentiates the effects of sunitinib malate in a rat breast cancer model
Yoanne Mousseau et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Induction of brain tumor stem cell apoptosis by FTY720: a potential therapeutic agent for glioblastoma
Adriana Estrada-Bernal et al.
NEURO-ONCOLOGY (2012)
Glioma-derived mutations in isocitrate dehydrogenase 2 beneficial to traditional chemotherapy
Yuejun Fu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Rapid Generation of In Vitro Multicellular Spheroids for the Study of Monoclonal Antibody Therapy
Yen T. Phung et al.
JOURNAL OF CANCER (2011)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
FTY720 (Fingolimod) Sensitizes Prostate Cancer Cells to Radiotherapy by Inhibition of Sphingosine Kinase-1
Dmitri Pchejetski et al.
CANCER RESEARCH (2010)
MGMT-Independent Temozolomide Resistance in Pediatric Glioblastoma Cells Associated with a PI3-Kinase-Mediated HOX/Stem Cell Gene Signature
Nathalie Gaspar et al.
CANCER RESEARCH (2010)
Sphingosine 1-phosphate and cancer
Nigel J. Pyne et al.
NATURE REVIEWS CANCER (2010)
Modulation of Invasive Properties of CD133(+) Glioblastoma Stem Cells: A Role for MT1-MMP in Bioactive Lysophospholipid Signaling
Borhane Annabi et al.
MOLECULAR CARCINOGENESIS (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: Consequences for mode of action in multiple sclerosis
Carolyn A. Foster et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1
Gerald Schmid et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Dimethylfumarate impairs melanoma growth and metastasis
Robert Loewe et al.
CANCER RESEARCH (2006)
Detailed characterization of the mouse glioma 261 tumor model for experimental glioblastoma therapy
Tunde Szatmari et al.
CANCER SCIENCE (2006)
Effects of a novel immunomodulating agent, FTY720, on tumor growth and angiogenesis in hepatocellular carcinoma
JWY Ho et al.
MOLECULAR CANCER THERAPEUTICS (2005)
FDA drug approval summary:: Erlotinib (Tarceva®) tablets
MH Cohen et al.
ONCOLOGIST (2005)
Share Paper
